AbbVie makes psychedelic play with $2bn Gilgamesh collaboration

The two companies will develop neuroplastogens for psychiatric disorders as psychedelic market activity ramps up.

Bayer reports drop in Q1 sales amidst patent litigation challenges

Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelto market in its Q1 update.

OCT Europe: Unless everyone is benefiting, what is the point?

A big topic at Arena International’s Outsourcing in Clinical Trials Europe 2024 is how everyone should benefit from clinical research.

NeuroSense taps PhaseV's ML tech for Phase III ALS trial analysis

PhaseV will analyse NeuroSense’s Phase II ALS trial data, and results from these will inform Phase III trial design, enrolment, and cost-effectiveness.

AriBio receives approval from China's NMPA to begin Alzheimer's treatment trial

The study aims to assess the efficacy and safety of AR1001 in treating patients with early Alzheimer's disease.

Medidata expands clinical trial software partnership with Worldwide Clinical Trials

The collaboration aims to help Worldwide's customers reduce trial timelines and improve site selection.

Genprex dosing subjects in trial of combination therapy for small-cell lung cancer

The company plans to begin the subsequent Phase II expansion study in the second half of this year.

15th Annual Outsourcing in Clinical Trials East Coast 2024

The upcoming Outsourcing in Clinical Trials Europe 2024 conference will explore advancements in the clinical trial industry.

Register Now